Neos Theraps Inc Drug Patent Portfolio
Neos Theraps Inc owns 2 orange book drugs protected by 7 US patents Given below is the list of Neos Theraps Inc's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11166947 | Effective dosing of a child for the treatment of ADHD with methylphenidate | 25 Jan, 2038 | Active |
| US8709491 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | 28 Jun, 2032 | Active |
| US9017731 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles | 28 Jun, 2032 | Active |
| US9265737 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles | 28 Jun, 2032 | Active |
| US9072680 | Compositions comprising methylphenidate complexed with ion-exchange resin particles | 28 Jun, 2032 | Active |
| US9089496 | Compositions comprising methylphenidate complexed with ion-exchange resin particles | 28 Jun, 2032 | Active |
| US8840924 | Compositions and methods of making rapidly dissolving ionically masked formulations | 05 Jun, 2026 | Active |
Latest Legal Activities on Neos Theraps Inc's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Neos Theraps Inc.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 29 Dec, 2022 | US9072680 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 21 Oct, 2022 | US9017731 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 09 Nov, 2021 | US11166947 |
|
Recordation of Patent Grant Mailed
Critical
| 09 Nov, 2021 | US11166947 |
|
Email Notification
Critical
| 21 Oct, 2021 | US11166947 |
|
Issue Notification Mailed
Critical
| 20 Oct, 2021 | US11166947 |
| Printer Rush- No mailing | 13 Oct, 2021 | US11166947 |
| Dispatch to FDC | 13 Oct, 2021 | US11166947 |
|
Application Is Considered Ready for Issue
Critical
| 13 Oct, 2021 | US11166947 |
| Miscellaneous Incoming Letter | 01 Oct, 2021 | US11166947 |
|
Email Notification
Critical
| 22 Sep, 2021 | US11166947 |
| Mail PUB other miscellaneous communication to applicant | 22 Sep, 2021 | US11166947 |
| PUB Other miscellaneous communication to applicant | 20 Sep, 2021 | US11166947 |
| Mail IDS Notice of Consideration | 16 Sep, 2021 | US11166947 |
|
Information Disclosure Statement considered
Critical
| 15 Sep, 2021 | US11166947 |
Neos Theraps Inc's Family Patents
Neos Theraps Inc Drug List
Given below is the complete list of Neos Theraps Inc's drugs and the patents protecting them.
1. Adzenys Er
Adzenys Er is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8709491 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles |
28 Jun, 2032
(7 years from now)
| Active |
| US9017731 | Composition comprising a mixture of dextro- and levo-amphetamines complexed with ion-exchange resin particles to form drug resin particles |
28 Jun, 2032
(7 years from now)
| Active |
| US9265737 | Pharmaceutical composition comprising amphetamines complexed with ion-exchange resin particles |
28 Jun, 2032
(7 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Adzenys Er's drug page
2. Cotempla Xr-odt
Cotempla Xr-odt is protected by 4 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11166947 | Effective dosing of a child for the treatment of ADHD with methylphenidate |
25 Jan, 2038
(13 years from now)
| Active |
| US9072680 | Compositions comprising methylphenidate complexed with ion-exchange resin particles |
28 Jun, 2032
(7 years from now)
| Active |
| US9089496 | Compositions comprising methylphenidate complexed with ion-exchange resin particles |
28 Jun, 2032
(7 years from now)
| Active |
| US8840924 | Compositions and methods of making rapidly dissolving ionically masked formulations |
05 Jun, 2026
(1 year, 6 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Cotempla Xr-odt's drug page